Patents by Inventor Ki Ryang KWEON

Ki Ryang KWEON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising derivative compound of 1,2-naphthoquinone for preventing or treating solid cancer or blood cancer
    Patent number: 11717511
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating solid cancer and blood cancers such as acute leukemia and chronic leukemia, comprising a derivative compound of 1,2-naphthoquinone or a pharmaceutically acceptable salt thereof as an effective component. The derivative compound of 1,2-naphthoquinone is highly effective in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus can be beneficially used as a pharmaceutical composition for preventing or treating cancers, especially solid cancers, acute leukemia, and chronic leukemia.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: August 8, 2023
    Assignee: HUEN CO., LTD.
    Inventors: Ki Ryang Kweon, Jun Young Heo, Min Ho Shong, Jeong Su Han, Min Jeong Ryu
  • Pharmaceutical composition including 1,2-naphthoquinone derivative compound for prevention or treatment of solid cancers or blood cancers
    Patent number: 11684610
    Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of solid cancers or blood cancers such as acute leukemia or chronic leukemia, including, as an active ingredient, a 1,2-naphthoquinone derivative compound or a pharmaceutically acceptable salt thereof, wherein the 1,2-naphthoquinone derivative compound has excellent effects in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus, can be useful as a pharmaceutical composition for the prevention or treatment of cancer, in particular, solid cancers, acute leukemia, or chronic leukemia.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: June 27, 2023
    Assignee: YUNGJIN PHARM. CO., LTD.
    Inventors: Ki Ryang Kweon, Jun Young Heo, Min Ho Shong, Jeong Su Han, Min Jeong Ryu
  • PHARMACEUTICAL COMPOSITION COMPRISING DERIVATIVE COMPOUND OF 1,2-NAPHTHOQUINONE FOR PREVENTING OR TREATING SOLID CANCER OR BLOOD CANCER
    Publication number: 20210155596
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating solid cancer and blood cancers such as acute leukemia and chronic leukemia, comprising a derivative compound of 1,2-naphthoquinone or a pharmaceutically acceptable salt thereof as an effective component. The derivative compound of 1,2-naphthoquinone is highly effective in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus can be beneficially used as a pharmaceutical composition for preventing or treating cancers, especially solid cancers, acute leukemia, and chronic leukemia.
    Type: Application
    Filed: April 4, 2019
    Publication date: May 27, 2021
    Applicant: HUEN Co., Ltd.
    Inventors: Ki Ryang KWEON, Jun Young HEO, Min Ho SHONG, Jeong Su HAN, Min Jeong RYU
  • PHARMACEUTICAL COMPOSITION INCLUDING 1,2-NAPHTHOQUINONE DERIVATIVE COMPOUND FOR PREVENTION OR TREATMENT OF SOLID CANCERS OR BLOOD CANCERS
    Publication number: 20210137893
    Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of solid cancers or blood cancers such as acute leukemia or chronic leukemia, including, as an active ingredient, a 1,2-naphthoquinone derivative compound or a pharmaceutically acceptable salt thereof, wherein the 1,2-naphthoquinone derivative compound has excellent effects in killing cancer cells of various solid cancers, acute leukemia, and chronic leukemia, and thus, can be useful as a pharmaceutical composition for the prevention or treatment of cancer, in particular, solid cancers, acute leukemia, or chronic leukemia.
    Type: Application
    Filed: April 4, 2019
    Publication date: May 13, 2021
    Inventors: Ki Ryang KWEON, Jun Young HEO, Min Ho SHONG, Jeong Su HAN, Min Jeong RYU